Helpline 07939 046 030

Teagan Martin’s first day at Canterbury Secondary School

13 September 2019

Teagan Martin's first day at Canterbury Secondary School

Born 15 weeks premature and weighing as much as a box of cereal Teagan was only supposed to have 24 hours to live. Fast forward 11 years later and Teagan's parents are sending her off to her first day of secondary school in Canterbury. It is a truly inspiring story which have left her parents with nothing but pride and admiration for their daughter who despite her struggles with NF continues to defy the odds and uplift those around her on a daily basis

"She’s done so well to get this far - she wasn’t meant to be here but she is. We’re well chuffed."

– Teagan's Father Ian

To read the full story then please click on the link below:

Filter News

Filter by Date
Category
Reset

New Research Study for Children and Young People with Neurofibromatosis Type 1

Find out more about the study and how you can participate here:

Read More

Nurse’s Conference 2019

Find out more about this year's conference with our Nurses here:

Read More

Nerve Tumours UK joins the “Embracing Complexity” Coalition

Find out more about the coalition we have decided to join

Read More

Researching NF1

Rory Deasy has conducted research into the treatment of children with NF1. Here he talks about his research journey.

Read More

Megan’s Journey

Megan talks about her experiences of being a student with NF and what she took away from the NF conference in San Fransico

Read More

Aldo goes to Primary School

Find out more about the book aimed at helping people understand the life of an autistic boy going through primary school here

Read More

Eva’s Races

Eva has run 3 races over the past year for NTUK, find out what has been motivating her here:

Read More

Carl’s Story in memory of his sister who had NF2

Carl recently hosted his own wrestling event in memory of his late sister, find out more on his story here:

Read More

Coordinated Care of Rare Diseases Study at UCL

Find out more about the study and how you can take part here:

Read More